文献速递心脑血管急症重症综合管理与镇静镇痛

重型创伤性脑损伤中的细胞因子反应:有烟是否就有火?

Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire?
PubMed 文献 · Neurocrit Care · 2019-01-01
一句话结论重型创伤性脑损伤中单一细胞因子不太可能足以准确判断预后,炎症细胞因子水平升高可能仅是严重损伤的标志而非直接因果因素。

本文为范围综述,检索Ovid MEDLINE、PUBMED和EMBASE数据库1995至2017年的文献,纳入动物模型和人类临床研究,最终评估141篇全文(126篇原创研究和15篇综述)。综述讨论了重型创伤性脑损伤中常研究的细胞因子(TNF-α、IL-1β、IL-6、TIMP-1、TGF-β、P物质和可溶性CD40配体)的基本功能和预后意义。作者认为,从现有文献理解来看,单一生物标志物不太可能足以准确判断重型创伤性脑损伤患者的预后;更严重的损伤会显示更高水平的炎症细胞因子,这可能与严重损伤标志相关,但这并不必然意味着这些细胞因子在患者不良结局中具有直接因果作用。需要进一步研究以更好地描述重型创伤性脑损伤期间复杂的全身炎症与中枢神经系统相互作用,之后才能将其用作可靠的预后工具。

要点

  • 从现有文献理解来看,单一生物标志物不太可能足以准确判断重型创伤性脑损伤患者的预后。
  • 更严重的损伤会显示更高水平的炎症细胞因子,这可能与严重损伤标志相关。
  • 细胞因子水平升高并不必然意味着这些细胞因子在患者不良结局中具有直接因果作用。
  • 需要进一步研究以更好地描述重型创伤性脑损伤期间复杂的全身炎症与中枢神经系统相互作用,之后才能将其用作可靠的预后工具。
  • 综述涵盖TNF-α、IL-1β、IL-6、TIMP-1、TGF-β、P物质和可溶性CD40配体等常研究的细胞因子。

适用人群与场景

  • 纳入动物模型和人类临床研究,包括急性(< 3个月)重型创伤性脑损伤,涵盖孤立性重型创伤性脑损伤和重型创伤性脑损伤合并全身损伤。

研究设计与关键结果

  • 范围综述检索Ovid MEDLINE、PUBMED和EMBASE数据库1995至2017年的文献,纳入原创研究和综述(含动物模型和人类临床研究)。
  • 应用纳入标准并去除重复后,评估141篇全文,包括126篇原创研究和15篇综述。
  • 由单一审阅者CC分两阶段完成综述:第一阶段审阅标题和摘要,第二阶段评估全文以确保相关性。
  • 综述讨论TNF-α、IL-1β、IL-6、TIMP-1、TGF-β、P物质和可溶性CD40配体在重型创伤性脑损伤中的基本功能和预后意义。

证据类型、等级与局限

  • 证据类型:范围综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,从现有文献理解来看,单一生物标志物不太可能足以准确判断重型创伤性脑损伤患者的预后。
  • 作者认为,更严重的损伤会显示更高水平的炎症细胞因子,这可能与严重损伤标志相关,但并不必然意味着这些细胞因子在患者不良结局中具有直接因果作用。
  • 作者认为,需要进一步研究以更好地描述重型创伤性脑损伤期间复杂的全身炎症与中枢神经系统相互作用,之后才能将其用作可靠的预后工具。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

This scoping review will discuss the basic functions and prognostic significance of the commonly researched cytokines implicated in severe traumatic brain injury (sTBI), including tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6, tissue inhibitor of matrix metalloproteinases-1 (TIMP-1), transforming growth factor-β (TGF-β), substance P, and soluble CD40 ligand (sCD40L). A scoping review was undertaken with an electronic search for articles from the Ovid MEDLINE, PUBMED and EMBASE databases from 1995 to 2017. Inclusion criteria were original research articles, and reviews including both animal models and human clinical studies of acute (< 3 months) sTBI. Selected articles included both isolated sTBI and sTBI with systemic injury. After applying the inclusion criteria and removing duplicates, 141 full-text articles, 126 original research articles and 15 review articles, were evaluated in compiling this review paper. A single reviewer, CC, completed the review in two phases. During the first phase, titles and abstracts of selected articles were reviewed for inclusion. A second evaluation was then conducted on the full text of all selected articles to ensure relevancy. From our current understanding of the literature, it is unlikely a single biomarker will be sufficient in accurately prognosticating patients with sTBI. Intuitively, a more severe injury will demonstrate higher levels of inflammatory cytokines which may correlate as a marker of severe injury. This does not mean, necessarily, these cytokines have a direct and causal role in the poor outcome of the patient. Further research is required to better delineate the complex systemic inflammatory and CNS interactions that occur during sTBI before they can be applied as a reliable prognostic tool.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Casault C, Al Sultan AS, Banoei M, et al. Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire? Neurocrit Care. 2019. PMID: 29569129. doi:10.1007/s12028-018-0522-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。